版本:
中国

BRIEF-Sciclone Pharmaceuticals - Sciclone Pharmaceuticals merger deal with consortium led by Gl Capital's termination fee set at $15.8 mln ‍​

June 8 Sciclone Pharmaceuticals Inc:

* Sciclone Pharmaceuticals - sciclone pharmaceuticals merger deal with consortium led by gl capital's termination fee set at $15.8 million - sec filing‍​ ‍​

* Sciclone pharmaceuticals inc - merger deal's reverse termination fee set at about $31.6 million ‍​ Source text (bit.ly/2rPG9qY) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐